> White Papers > Actiance, Inc. > Social Media Risks and Benefits for the Pharmaceutical Industry
 

Social Media Risks and Benefits for the Pharmaceutical Industry

Actiance, Inc.

Social Media Risks and Benefits for the Pharmaceuticals Industry
Drug makers are just beginning to realize how social networks can improve business processes. Social media helps your organization share information and exchange ideas with your customers quickly, but doing so can involve considerable risk. Thatís because social media is subject to the scrutiny of regulators, legislators, and litigators. So, what seems like a spoon full of sugar is often a tough pill to swallow when you consider regulatory requirements from agencies like the FDA. On top of that, increasing litigation has made it a business requirement to consider solutions that help bring down skyrocketing legal costs. Not having technology in place to help manage these requirements and increasing risks, or doing so without careful planning, can be a costly mistake.

Read this paper to gain an understanding of:

  • What the regulatory landscape of the pharmaceuticals industry looks like
  • What concerns you should be aware of from a legal perspective

Tags : social media, increased risks, business processes, regulatory requirements, it management


* Please enter your email address and click the Download Now button to download the white paper.

 Email this page
Published:  Jan 15, 2015
Length:  22
Type:  White Paper